108 related articles for article (PubMed ID: 21435118)
1. FVIII replacement in 12-day-old newborn with haemophilia A requiring surgical repair of D transposition of great arteries.
Kuzmanovic M; Stajevic M; Vukomanovic V; Serbic O; Jankovic B
Haemophilia; 2011 Sep; 17(5):821-2. PubMed ID: 21435118
[No Abstract] [Full Text] [Related]
2. Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor.
Jones AE; Roy A; Armstrong T; Rees M; Welsh FK
Haemophilia; 2009 Nov; 15(6):1332-3. PubMed ID: 19624759
[No Abstract] [Full Text] [Related]
3. Management of hemophilia A and B during surgical correction of transposition of the great arteries.
Roskos RR; Gilchrist GS; Kazmier FJ; Feldt RH; Danielson GK
Mayo Clin Proc; 1983 Mar; 58(3):182-6. PubMed ID: 6827862
[TBL] [Abstract][Full Text] [Related]
4. Perioperative Hemostatic Management of a Newborn With Hereditary Hemophilia A Undergoing Emergent Surgery for Dextro-Transposition of the Great Arteries.
Torfs A; Chardonnal L; Meunier S; Désage S; Henaine R; Lilot M
J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3855-3858. PubMed ID: 35879147
[TBL] [Abstract][Full Text] [Related]
5. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Brackmann HH; Gormsen J
Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
[No Abstract] [Full Text] [Related]
6. Haemophilia A associated with Down's syndrome.
Kaczorowska-Hac B; Wlazlowski M; Wierzba J; Balcerska A
Ann Hematol; 2013 Jun; 92(6):841-2. PubMed ID: 23150201
[No Abstract] [Full Text] [Related]
7. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A.
Stine KC; Becton DL
Haemophilia; 2006 Jul; 12(4):435-6. PubMed ID: 16834747
[TBL] [Abstract][Full Text] [Related]
8. Massive retroperitoneal haemorrhage in a neonate with severe haemophilia A.
Grizelj R; Vuković J; Bilić E; Stern-Padovan R
Haemophilia; 2011 May; 17(3):547-8. PubMed ID: 21070491
[No Abstract] [Full Text] [Related]
9. Arterial pseudoaneurysms in haemophilia: conservative treatment with observation and factor replacement.
Drew M; Yu JC; Michaels LA
Haemophilia; 2011 May; 17(3):550-2. PubMed ID: 21118336
[No Abstract] [Full Text] [Related]
10. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.
Richards M; Williams M; Chalmers E; Liesner R; Collins P; Vidler V; Hanley J;
Br J Haematol; 2010 May; 149(4):498-507. PubMed ID: 20230411
[TBL] [Abstract][Full Text] [Related]
11. A case report of a premature infant with haemophilia A and factor VIII inhibitor.
Cartledge P; Deakin K; McKecknie L; Richards M
Haemophilia; 2011 Jul; 17(4):711-2. PubMed ID: 21371187
[No Abstract] [Full Text] [Related]
12. Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate(®), in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients.
Klukowska A; Windyga J; Batorova A
Thromb Res; 2011 Mar; 127(3):247-53. PubMed ID: 21220152
[TBL] [Abstract][Full Text] [Related]
13. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid in the control of spontaneous bleeding in severe haemophilia.
Rainsford SG; Jouhar AJ; Hall A
Thromb Diath Haemorrh; 1973 Nov; 30(2):272-9. PubMed ID: 4773366
[No Abstract] [Full Text] [Related]
15. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
Bloom AL; Emmanuel JH
Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
[No Abstract] [Full Text] [Related]
16. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.
Martinowitz U; Luboshitz J; Bashari D; Ravid B; Gorina E; Regan L; Stass H; Lubetsky A
Haemophilia; 2009 May; 15(3):676-85. PubMed ID: 19298381
[TBL] [Abstract][Full Text] [Related]
17. [Bleeding in haemophilia during massive treatment with anti-haemophilic globulin (author's transl)].
Sutor AH; Jesdinsky-Buscher C
Dtsch Med Wochenschr; 1975 May; 100(21):1183-6. PubMed ID: 1132328
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.
Rea C; Dunkerley A; Sørensen B; Rangarajan S
Haemophilia; 2009 Nov; 15(6):1237-42. PubMed ID: 19664015
[TBL] [Abstract][Full Text] [Related]
19. Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension.
Luciani GB; Chang AC; Starnes VA
Ann Thorac Surg; 1996 Mar; 61(3):800-5. PubMed ID: 8619696
[TBL] [Abstract][Full Text] [Related]
20. Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein BM
Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
